Hyperfine Inc
NASDAQ:HYPR
Hyperfine Inc
Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. The company is headquartered in Guilford, Connecticut and currently employs 136 full-time employees. The company went IPO on 2021-01-27. The firm provides a Swoop system, which is a portable magnetic resonance imaging (MRI) system capable of providing neuroimaging at the point of care. Its Swoop Portable Magnetic Resonance Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional MRI scanners. MRI is a medical imaging technique used in radiology to image the human body’s anatomy and physiological processes. MRI is used in various clinical settings for medical diagnosis, the staging of disease, and follow-up treatment. The company designed its Swoop system to address an unmet need in point-of-care medical imaging through a combination of hardware and Artificial intelligence (AI)-powered software services. Its hardware uses modern computational power and deep learning advances. Its software addresses the traditional ease-of-use and integration challenges often presented by specialized medical technologies.
Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. The company is headquartered in Guilford, Connecticut and currently employs 136 full-time employees. The company went IPO on 2021-01-27. The firm provides a Swoop system, which is a portable magnetic resonance imaging (MRI) system capable of providing neuroimaging at the point of care. Its Swoop Portable Magnetic Resonance Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional MRI scanners. MRI is a medical imaging technique used in radiology to image the human body’s anatomy and physiological processes. MRI is used in various clinical settings for medical diagnosis, the staging of disease, and follow-up treatment. The company designed its Swoop system to address an unmet need in point-of-care medical imaging through a combination of hardware and Artificial intelligence (AI)-powered software services. Its hardware uses modern computational power and deep learning advances. Its software addresses the traditional ease-of-use and integration challenges often presented by specialized medical technologies.
Revenue Growth: Hyperfine reported Q3 revenue of $3.4 million, up 27% sequentially, driven by the launch of its next-generation Swoop system and Opti AI software.
Record Margins: Gross margin reached a record 53.8%, improving by 450 basis points from the prior quarter due to higher average selling prices.
Reduced Cash Burn: Net cash burn (excluding financing) dropped 27% sequentially, reflecting continued spending discipline.
Strong Balance Sheet: Over $20 million was raised in October, extending the company’s cash runway into the second half of 2027.
Robust Guidance: Q4 revenue is expected to be $5–6 million, up 60% sequentially at the midpoint, and full year 2025 revenue is guided to $13–14 million with gross margins expected at 49–51%.
Commercial Momentum: Company is seeing strong demand and a growing, diversified pipeline across U.S. hospitals, neurology offices, and international markets.
